68 results on '"Mellor-Pita, S."'
Search Results
2. Decrease of regulatory T cells in patients with systemic lupus erythematosus
3. Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity
4. Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus
5. Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity.
6. Tratamiento con adalimumab del eritema nudoso crónico refractario
7. Genotypic distribution of polymorphisms within endosomal TLR receptor genes in Spanish healthy women
8. Ciclosporina A en el tratamiento de la nefropatía lúpica resistente a ciclofosfamida y a micofenolato de mofetil: a propósito de un caso
9. Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus.
10. Ciclosporina A en el tratamiento de la nefropatía lúpica resistente a ciclofosfamida y a micofenolato de mofetil: a propósito de un caso
11. Caso 1. Lesiones hiperpigmentadas y fotosensibles asociadas a síndrome carcinoide
12. Varón de 25 años con debilidad muscular y alteraciones electrocardiográficas tras ejercicio físico
13. Acanthosis Nigricans: A New Manifestation of Insulin Resistance in Patients Receiving Treatment with Protease Inhibitors
14. A 35-year-old male with neurosensitive hearing loss and interstitial [2] | Varón de 35 años con sordera neurosensorial y queratitis intersticial
15. Polyarthritis caused by Leishmania in a patient with human immunodeficiency virus [1]
16. Enfermedad de Von Recklinghausen y masa abdominal
17. Giant cell arteritis associated with demyelinating polyradiculoneuropathy.
18. Genotypic distribution of polymorphisms within endosomal TLR receptor genes in Spanish healthy women.
19. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients.
20. Rapid response to anifrolumab in refractory cutaneous lupus erythematosus.
21. Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry.
22. Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry.
23. Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry.
24. Impact of severe infections in SLE: an observational study from the Spanish national registry.
25. Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study.
26. Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.
27. Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus.
28. Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry.
29. Temporal Arteritis in a Young Patient. A Clinical Case.
30. Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients.
31. Pleural effusion associated to metimazol.
32. Idiopathic relapsing acute pericarditis: Report of one case with favorable response to anakinra.
33. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
34. Genotypic distribution of common variants of endosomal toll like receptors in healthy Spanish women. A comparative study with other populations.
35. [Vogt-Koyanagi-Harada disease].
36. [Refractory chronic erythema nodosum treated with adalimumab].
37. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
38. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
39. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
40. [Not Available].
41. Common variable immunodeficiency in systemic lupus erythematosus.
42. Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis.
43. [Middle lobe bronchiectasis and Mycobacterium avium complex infection: the Lady Windermere syndrome].
44. [Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report].
45. [Exposition. Case 1. Hyperpigmented and photosensitive lesions associated to carcinoid syndrome].
46. [25-year-old male with muscular weakness and electrocardiographic changes after exercise].
47. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.
48. Polyarthritis caused by Leishmania in a patient with human immunodeficiency virus.
49. Cerebral embolism complicating Libman-Sacks endocarditis--full recovery using recombinant tissue plasminogen activator.
50. [Male with human immunodeficiency virus infection and hematuria].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.